- Softened demand in core pain relief segment post-COVID.
- Shift towards oral analgesics.
- Supply chain disruptions due to geopolitical events (Red Sea, Suez Canal, Russia-Ukraine war).
- Increased packaging material costs.
AMRUTANJAN HEALTH CARE LIMITED
Greenhouse gas emissions & sustainability report data
In its 2023-24 reporting, AMRUTANJAN HEALTH CARE LIMITED disclosed greenhouse gas emissions of 1.4K tCO2e (Scope 1 & 2). By scope: Scope 1: 453.656 tCO2e; Scope 2: 989.775 tCO2e. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
1.4K tCO2e (Scope 1 & 2)
2023-24
Water Usage
44.7K kl
2023-24
Waste
51.6 tons
2023-24
📊 Emissions by Scope (2023-24)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 453.656 tCO2e |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 989.775 tCO2e |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2023-24 | 1.4K tCO2e (Scope 1 & 2) |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Transitioned from plastic to glass bottles for Maha Strong Balm
- Implemented an EPR system for responsible waste management
🎯 Climate & Sustainability Targets
🔜 Short-term
- Improve and sustain operating margins in the mid-teens.
📅 Medium-term
- Achieve annualized volume and value growth for the mid-term to be in the range of 9-10% in headache relief category.
🔭 Long-term
- Achieve a revenue of ₹1,000 crore (₹10 Billion) by 2028.
🌱 ESG Focus Areas
Environmental SustainabilitySocial ImpactEthical Business Practices